Abraxis Bioscience Inc.
(NASDAQ:ABII)|
54.48 +1.48 (2.79%) Dec 04 - Close |
|
|
|
After-Hours 54.16 -0.32 (-0.59%) Thu, 4 Dec 2008 7:40 PM
- Compare ABII with:
- View: Line | Candlestick
Company Profile
Abraxis Bioscience Inc.
11755 Wilshire Blvd.
Los Angeles, CA 90025
United States - Map
Phone: (310) 883-1300
Fax: (310) 998-8553
Website: www.abraxisbio.com
State of incorporation: Delaware
CEO: Dr. Patrick Soon-Shiong, M.D.
Employees: 615
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biotechnology company
An integrated biotechnology Company, dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses.
Recent news for ABII
-
Abraxis Fires AstraZeneca, Gets Fired Up
Motley Fool - Nov 26 at 1:00 ET
-
Motley Fool - Nov 25 at 2:24 ET
-
InPlay: Abraxis BioScience announces agreement to re-acquire exclusive US rights to Abraxane
Briefing.com - Nov 25 at 8:08 ET
-
AstraZeneca plans to end Abraxis deal
AP - Nov 25 at 8:06 ET
-
Business Wire - Nov 25 at 8:05 ET
-
REFILE-UPDATE - AstraZeneca, Abraxis set to end cancer drug deal
Reuters - Nov 25 at 2:43 ET
-
UPDATE - AstraZeneca, Abraxis set to end cancer drug deal
Reuters - Nov 25 at 2:40 ET
-
ABRAXIS BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Nov 24 at 5:10 ET
-
Bristol Rolls Snake Eyes in Europe
Motley Fool - Nov 24 at 3:02 ET
-
ABRAXIS BIOSCIENCE, INC. Financials
EDGAR Online Financials - Nov 21 at 9:04 ET
Top members owning ABII
-
New
5.71%3m:
5.71%YTD:
-
Top 45%
-31.05%3m:
-30.36%YTD:
-
Top 52%
-34.39%3m:
-34.39%YTD: